Delivery Order SPE2DB20D1109-SPE2DB23FP99D
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TNKASE 50 MG KITS, a pharmaceutical product, with a firm fixed price ceiling value of $5,463.86 and a performance period ending on July 8, 2025. The contract is not set aside and was awarded on July 7, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $4,581.92 firm fixed-price contract is for the supply of TNKASE 50 MG KITS, a type of specialty medication. The contract has a completion date of September 27, 2024. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued at up to $999,999,999 and $750,000 respectively, which serve as...
- This is a Delivery Order award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division, valued at $13,850.71. The contract is for the supply of TNKASE 50 MG KITS, a pharmaceutical product, with a period of performance through October 10, 2024. This award is not associated with a set-aside program. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including military...
- The Defense Logistics Agency (DLA) awarded a delivery order contract valued at $39,474.69 to AmerisourceBergen Drug Corp for TNKASE 50 MG kits on October 16, 2025, with completion scheduled for October 17, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child award under AmerisourceBergen's broader Indefinite Delivery...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company, for the delivery of 4565040776 TNKASE 50 MG KITS. The contract has a ceiling value of $13,745.76 and is a Delivery Order with a Firm Fixed Price pricing type. The award date is July 1, 2024, and the ultimate completion date is July 2, 2024. This contract does not have a set-aside designation. AmerisourceBergen Drug Corp holds a significant...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the provision of 4564593515 TNKASE 50 MG KITS, a pharmaceutical product, with a ceiling value of $12,168.13 and a firm fixed price. The contract has a completion date of May 15, 2024. AmerisourceBergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The order is for the supply of a variety of pharmaceutical products and medical supplies, including prescription medications, over-the-counter drugs, and critical care materials such as syringes and test kits. The delivery order, valued at $31,336.32, is a firm fixed-price contract with an ultimate completion date of April 16, 2024....
- The Defense Logistics Agency awarded a delivery order valued at $15,168.42 to AmerisourceBergen Drug Corp for the supply of Tenkase 50 mg kits. This is a firm fixed-price contract with no set-aside designation, representing a competitive award issued on December 18, 2025, with an ultimate completion date of December 19, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's larger...
- This is a delivery order awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of pharmaceutical products and medical supplies, including medications across various therapeutic areas such as diabetes, neurology, pain management, and specialized treatments. The contract has a ceiling value of $675,212.59 and a completion date of March 28, 2024. It is a firm fixed-price delivery order...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The order is for the supply of pharmaceutical products and medical supplies, with a ceiling value of $1,110.54. The contract is a Firm Fixed Price delivery order, with no set-aside designation. Amerisourcebergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB23FP99DDelivery Order
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4562278585 ! TNKASE 50 MG KITS, a pharmaceutical product, with a ceiling value of $4,566.78 and a completion date of September 25, 2023. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions worldwide. The company also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.6k | 9/22/23 |